[1]
N. Wasel, Y. Dutronc, B. Schinzel, and J.-P. Lacour, “Comparison of Ixekizumab and Ustekinumab Efficacy in the Treatment of Nail Lesions of Patients With Moderate-to-Severe Plaque Psoriasis: 52-Week Data From the IXORA-S Trial”, J of Skin, vol. 2, p. S117, Dec. 2018.